Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat

Shock. 1998 May;9(5):336-40. doi: 10.1097/00024382-199805000-00004.

Abstract

The aim of the present study was to investigate the role of poly(ADP-ribose) synthetase in a nonseptic shock model, wherein oxyradicals, nitric oxide, and peroxynitrite are known to play a crucial role in the inflammatory process. DNA single-strand breakage and activation of the nuclear enzyme poly(ADP-ribose) synthetase (PARS) triggers an energy-consuming, inefficient repair cycle, which contributes to peroxynitrite-induced cellular injury. Here we investigated whether peroxynitrite production and PARS activation are involved in cytotoxicity in macrophages collected from rats subjected to zymosan-induced shock. Macrophages harvested from the peritoneal cavity exhibited a significant production of peroxynitrite, as measured by the oxidation of the fluorescent dye dihydrorhodamine 123. Furthermore, zymosan-induced shock caused a suppression of macrophage mitochondrial respiration, DNA strand breakage, activation of PARS, and reduction of NAD+ cellular levels. In vivo treatment with 3-aminobenzamide (10 mg/kg intraperitoneally, 1 and 6 h after zymosan injection) or nicotinamide (50 mg/kg intraperitoneally, 1 and 6 h after zymosan injection) significantly inhibited the decrease in mitochondrial respiration and the activation of PARS, and partially restored the cellular level of NAD+. In a separate group of experiments, in vivo pretreatment with NG-nitro-L-arginine methyl ester, a nonselective inhibitor of nitric oxide synthesis (10 mg/kg intraperitoneally, 15 min before zymosan administration), reduced peroxynitrite formation and prevented the appearance of DNA damage, the decrease in mitochondrial respiration, and the loss of cellular levels of NAD+. Our study suggests that formation of peroxynitrite and subsequent activation of PARS may alter macrophage function in inflammatory processes and inhibition of nitric oxide, and that PARS may be a novel pharmacological approach to prevent cell injury in inflammation.

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • DNA Damage*
  • Disease Models, Animal
  • Energy Metabolism / drug effects*
  • Enzyme Activation
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / physiology*
  • Male
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • NAD / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Niacinamide / pharmacology
  • Nitrates / physiology*
  • Nitric Oxide Synthase / metabolism
  • Oxidants / physiology
  • Oxygen Consumption
  • Poly(ADP-ribose) Polymerases / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Shock / physiopathology*
  • Zymosan

Substances

  • Benzamides
  • Nitrates
  • Oxidants
  • NAD
  • Niacinamide
  • peroxynitric acid
  • 3-aminobenzamide
  • Zymosan
  • Nitric Oxide Synthase
  • Poly(ADP-ribose) Polymerases
  • NG-Nitroarginine Methyl Ester